...
首页> 外文期刊>Journal of Natural Science Biology and Medicine >Antibiotic resistance pattern of Enterococci isolates from nosocomial infections in a tertiary care hospital in Eastern India
【24h】

Antibiotic resistance pattern of Enterococci isolates from nosocomial infections in a tertiary care hospital in Eastern India

机译:印度东部一家三级医院的医院感染肠球菌分离株的抗生素耐药性

获取原文
           

摘要

Background:Resistance to commonly used antibiotics by Enterococci causing nosocomial infections is of concern, which necessitates judicious, responsible and evidence-based use of antibiotics. The present study was conducted to review the prevalence and identify therapeutic options for nosocomial Enterococcal infections in our tertiary care hospital.Materials and Methods:Isolates identified by morphological and biochemical characteristics were tested for antibiotic susceptibility using Kirby-Bauer method.Result:153 of 2096 culture positive clinical samples comprised of 101 urine, 30 wound swab/pus, 13 blood and 09 high vaginal swab isolates were identified as Enterococcus faecalis (90.85%), Enterococcus faecium (8.50%) and Enterococcus gallinarum (0.65%). Enterococci accounted for 8.45%, 4.53%, 4.23%, 4.43% of urinary, wound swab or pus, blood, high vaginal swab isolates respectively, causing 7.3% of all nosocomial infections. Significant number of Enterococci isolated from nosocomial urinary tract infection (66.01%) and wound infections (19.6%) were multidrug resistant (MDR). Although all isolates were sensitive to vancomycin and linezolid, resistance to erythromycin (71.24%) and ciprofloxacin (49.67%) was frequently observed. High-level gentamicin resistance was observed in 43.88%, and 61.53% of E. faecalis and E. faecium isolates respectively. Minimal inhibitory concentration of vancomycin of all the isolates were ≤1 μg/ml. 7% of the Enterococcal isolates were MDR strains and vancomycin or linezolid were the only effective antibiotics.Conclusion:A combination of vancomycin and/or linezolid were effective against Enterococci causing nosocomial infections in our tertiary care facility, nevertheless continuous and frequent surveillance for resistance patterns are necessary for judicious and evidence based use of antibiotics.
机译:背景:肠球菌对引起医院感染的常用抗生素的耐药性值得关注,这需要明智,负责和循证使用抗生素。本研究旨在回顾我们三级医院医院内肠球菌感染的患病率并确定治疗方案。材料与方法:使用形态学和生化特征鉴定的分离物采用Kirby-Bauer方法检测抗生素的敏感性。结果:2096年第153页培养阳性的临床样本包括101尿,30伤口拭子/脓,13血液和09高阴道拭子分离物,被鉴定为粪肠球菌(90.85%),粪肠球菌(8.50%)和鸡肠球菌(0.65%)。肠球菌分别占泌尿,伤口拭子或脓液,血液,高阴道拭子分离株的8.45%,4.53%,4.23%,4.43%,造成所有医院感染的7.3%。从医院泌尿道感染中分离出的肠球菌数量(66.01%)和伤口感染(19.6%)为多药耐药性(MDR)。尽管所有分离株均对万古霉素和利奈唑胺敏感,但经常观察到对红霉素(71.24%)和环丙沙星(49.67%)的耐药性。在粪肠球菌和粪肠球菌分离物中分别观察到高水平的庆大霉素抗性,分别为43.88%和61.53%。所有分离株的万古霉素最低抑菌浓度≤1μg/ ml。肠球菌分离株的7%是MDR菌株,万古霉素或利奈唑胺是唯一有效的抗生素。结论:万古霉素和/或利奈唑胺的组合可有效预防肠球菌在我们的三级医疗机构中引起医院内感染,但持续不断地监测耐药模式是明智和循证使用抗生素所必需的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号